(Q37057313)

18 August 2017

1 reference

title

Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry (English)

1 reference

18 August 2017

0 references

1 reference

1

Christoph Hiemke

1 reference

18 August 2017

15 January 2008

1 reference

European Journal of Clinical Pharmacology

18 August 2017

1 reference

18 August 2017

64

1 reference

18 August 2017

159-166

1 reference

18 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-007-0430-1

18 August 2017

0 references

cites work

Factors affecting chlorpromazine plasma levels in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0430-1

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0430-1

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0430-1

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0430-1

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0430-1

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

21 January 2018

1 reference

12 December 2020

Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".

1 reference

12 December 2020

Cytochrome P450 nomenclature, 2004.

1 reference

12 December 2020

Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach

1 reference

12 December 2020

Fluvoxamine-tricyclic antidepressant interaction

1 reference

12 December 2020

The history of clozapine

1 reference

12 December 2020

Use of plasma level monitoring of antidepressants in clinical practice. Towards an analysis of clinical utility

1 reference

12 December 2020

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

12 December 2020

Elevated antidepressant plasma levels after addition of fluoxetine

1 reference

12 December 2020

Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry

1 reference

12 December 2020

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

12 December 2020

Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping

1 reference

12 December 2020

Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection

1 reference

12 December 2020

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

1 reference

12 December 2020

The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis

1 reference

12 December 2020

Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in Man

1 reference

12 December 2020

Correlation of Subjective Side Effects with Plasma Concentrations of Nortriptyline

1 reference

12 December 2020

Cost-effectiveness of therapeutic drug monitoring: a systematic review.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

12 December 2020

Elevated levels of clozapine in serum after addition of fluvoxamine

1 reference

12 December 2020

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance

1 reference

12 December 2020

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

12 December 2020

What the clinician still has to be reminded of

1 reference

12 December 2020

Antipsychotic medication adherence: is there a difference between typical and atypical agents?

1 reference

12 December 2020

Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care

1 reference

12 December 2020

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration

1 reference

12 December 2020

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

12 December 2020

Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients.

1 reference

12 December 2020

Column switching and high-performance liquid chromatography in the analysis of amitriptyline, nortriptyline and hydroxylated metabolites in human plasma or serum

1 reference

12 December 2020

Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring

1 reference

12 December 2020

The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia

1 reference

12 December 2020

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

12 December 2020

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

1 reference

12 December 2020

Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs

1 reference

12 December 2020

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia

1 reference

12 December 2020

Optimizing early prediction for antipsychotic response in schizophrenia.

1 reference

12 December 2020

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

1 reference

12 December 2020

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

12 December 2020

Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride

1 reference

12 December 2020

Assessment of CYP1A2 activity in clinical practice: why, how, and when?

1 reference

12 December 2020

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

1 reference

12 December 2020

Neuroleptic Plasma Levels

1 reference

12 December 2020

Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?

1 reference

12 December 2020

All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis

1 reference

12 December 2020

How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?

1 reference

12 December 2020

Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable

1 reference

12 December 2020

Current role of LC-MS in therapeutic drug monitoring

1 reference

12 December 2020

Early prediction of antipsychotic nonresponse among patients with schizophrenia

1 reference

12 December 2020

Therapeutic monitoring of new antipsychotic drugs

1 reference

12 December 2020

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

12 December 2020

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

12 December 2020

Clozapine in treatment-resistant schizophrenics

1 reference

12 December 2020

Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders

1 reference

12 December 2020

Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.

1 reference

12 December 2020

10.1007/S00228-007-0430-1

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18196227